Neural-Network Identification of Clinical Target Distribution
摘要
Abstract
This paper presents a neural network-based algorithm for Clinical Target Distribution (CTD) identification integrated within a proton therapy treatment planning system, with validation against simulated MRI-derived ground truth data. The proposed CTD methodology demonstrates significant improvements in organ-at-risk (OAR) preservation, achieving a mean dose reduction of 29.3% to critical structures while maintaining robust target coverage (98.2%).